Overview
- 19 FDA inspections are on record.
- 12 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-03-25.
At a glance
Inspections
19
Form 483s
12
EIRs
2
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 17 Mar 2026 – 25 Mar 2026 | Human Drugs | 483 | On file |
| 10 Apr 2023 – 19 Apr 2023 | Human Drugs | 483 | View 483 → |
| 3 Sep 2019 – 6 Sep 2019 | Animal Drugs & Feeds | Clean | |
| 21 Feb 2018 – 1 Mar 2018 | Human Drugs | 483 | On file |
| 6 Jul 2015 – 22 Jul 2015 | Human Drugs | 483 | View 483 → |
| 3 Feb 2014 – 10 Feb 2014 | Human Drugs | 483 | View 483 → |
| 18 Mar 2013 – 27 Mar 2013 | Human Drugs | 483 | View 483 → |
| 23 Feb 2012 | Not recorded | 483 | View 483 → |
| 17 Jun 2011 | Not recorded | 483 | View 483 → |
| 24 Jan 2011 | Not recorded | Clean | |
| 23 Apr 2010 | Not recorded | 483 | On file |
| 10 Jul 2009 | Not recorded | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
19 Apr 2023
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Joey V Quitania, Crystal Monroy, Rachel C Stanton
19 Apr 2023
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Joey V Quitania, Crystal Monroy, Rachel C Stanton
19 Apr 2023
21 CFR 211.68(a)
Written calibration / inspection records not kept
Cited by Joey V Quitania, Crystal Monroy, Rachel C Stanton
19 Apr 2023
21 CFR 211.68(a)
Written calibration / inspection records not kept
Cited by Joey V Quitania, Crystal Monroy, Rachel C Stanton
22 Jul 2015
21 CFR 211.100(b)
SOPs not followed / documented
Cited by Theresa Kirkham, Paul A Bonneau, Virgilio F Pacio
Investigators
FDA investigators tied to this site in the record.
Virgilio F Pacio7 insp.
Joey V Quitania2 insp.
Linda Thai2 insp.
Jennifer M Gogley2 insp.
Sara H Gabel1 insp.
Homero W Aguilar1 insp.
Ana-Maria A Plapcianu1 insp.
Gloria E Andia1 insp.
Alexandra A Cole1 insp.
Crystal Monroy1 insp.
Rachel C Stanton1 insp.
Saied A Asbagh1 insp.
Santiago Gallardo Johnson1 insp.
Anita Narula1 insp.
Allison A Rodriguez1 insp.
Theresa Kirkham1 insp.
Paul A Bonneau1 insp.
Matthew J Johnson1 insp.
Caryn M Mcnab1 insp.
Kim L Thomas Cruse1 insp.
Jeremy H Nguyen1 insp.
Babajide M Osunsanmi1 insp.
Jeremy Beber1 insp.
Thomas R Beilke1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.103 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.186(b)(9) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(12) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(iii) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.56(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.80(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.87 | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Pacira Pharmaceuticals, Inc.'s 12 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat